Abstract:Abstract Background Bone marrow-derived stromal cells (MSC) are attractive targets for ex vivo cell and gene therapy. In this context, we investigated the feasibility of a plasmid-based strategy for genetic modification of human (h)MSC with enhanced green fluorescent protein (EGFP) and neurotrophin (NT)3. Three genetically modified hMSC lines (EGFP, NT3, NT3-EGFP) were established and used to study cell survival and transgene expression following transplantation in rat spinal cord. Results First, we demonstrate long-term survival of transplanted hMSC-EGFP cells in rat spinal cord under, but not without, appropriate immune suppression. Next, we examined the stability of EGFP or NT3 transgene expression following transplantation of hMSC-EGFP, hMSC-NT3 and hMSC-NT3-EGFP in rat spinal cord. While in vivo EGFP mRNA and protein expression by transplanted hMSC-EGFP cells was readily detectable at different time points post-transplantation, in vivo NT3 mRNA expression by hMSC-NT3 cells and in vivo EGFP protein expression by hMSC-NT3-EGFP cells was, respectively, undetectable or declined rapidly between day 1 and 7 post-transplantation. Further investigation revealed that the observed in vivo decline of EGFP protein expression by hMSC-NT3-EGFP cells: (i) was associated with a decrease in transgenic NT3-EGFP mRNA expression as suggested following laser capture micro-dissection analysis of hMSC-NT3-EGFP cell transplants at day 1 and day 7 post-transplantation, (ii) did not occur when hMSC-NT3-EGFP cells were transplanted subcutaneously, and (iii) was reversed upon re-establishment of hMSC-NT3-EGFP cell cultures at 2 weeks post-transplantation. Finally, because we observed a slowly progressing tumour growth following transplantation of all our hMSC cell transplants, we here demonstrate that omitting immune suppressive therapy is sufficient to prevent further tumour growth and to eradicate malignant xenogeneic cell transplants. Conclusion In this study, we demonstrate that genetically modified hMSC lines can survive in healthy rat spinal cord over at least 3 weeks by using adequate immune suppression and can serve as vehicles for transgene expression. However, before genetically modified hMSC can potentially be used in a clinical setting to treat spinal cord injuries, more research on standardisation of hMSC culture and genetic modification needs to be done in order to prevent tumour formation and transgene silencing in vivo .

Transfection of rat bone marrow stromal cells with NgR ecto genes by lentiviral vector

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

A Study on Transfecting Green Fluorescent Protein Gene to Rat Bone Marrow Mesenchymal Stem Cells

Construction and Identification of Lentiviral Expression Vector for Ngb Gene

Construction and expression of recombinant eukaryotie expression vector human NGF-β gene in spinal cord-derived neural stem cells

Bone Mesenchymal Stem Cells for Gene Transfer of NGF to the Adult Rat Brain: Rescue the NGFR P75 Positive Neurons from Fimbria–fornix Lesion-Induced Degeneration

Construction and transfection of the lentiviral vector containing glial cell line derived neurotrophic factor of rat

Enhanced green fluorescent protein gene-modified human bone marrow stromal cells induced by lentivirus

Lentiviral Vector Mediates Exogenous Gene Expression in Adult Rat DRG Following Peripheral Nerve Remote Delivery

Transfection of Schwann cells with retrovirus pLNCX2-GDNF and its expression

[Construction of Eukaryotic Expression Vector for Human Glial Derived Neurotrophic Factor and Its Expression in Spinal Cord Tissue of SD Rat].

Human nerve growth factor beta-modified bone marrow mesenchymal stem cells from the rabbit mandible by transfection of lentiviral vectors

Expression of Neurturin Gene in the Bone Marrow Stromal Cells of Rats in Vitro

RAT GDNF GENE TRANSFECTION AND EXPRESSION OF ITS Mrna AND PROTEIN IN SCHWANN CELLS

[Silenced NgR Gene Expression by RNA Interference to Promote Rats Facial Nerve Regeneration in Vitro].

[Cloning of NEP1-40 Gene and Expression of Its Protein].

Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord

Transfection of Exogenous Gene: Lac Z into Spinal Cord of SD Rats and Its Protein Expression: an in Vivo Study

Construction and identification of recombinant adeno-associated virus shuttle vector co-expressing nogo66-siRNA and nerve growth factor-β genes

[Construction and Screening of Neurite Outgrowth Inhibitory 66 Eukaryotic Expression Vectors].

Transplantation of BDNF Gene Recombinant Mesenchymal Stem Cel Ls and Adhesive Peptide-modified Hydrogel Scaffold for Spinal Cord Repa Ir